Bioio Overview
- Year Founded
-
2019
- Status
-
Private
- Employees
-
3
- Latest Deal Type
-
Later Stage VC
- Investors
-
6
Bioio General Information
Description
Developer of a mechanism of action technologies platform designed to study how a chemical or drug produces a biological effect. The company's platform uses focused ultrasound to ensure the drug efficacy and the reason behind the failure of therapies, enabling clients to focus on identifying drugs precisely targeting specific proteins.
Contact Information
Website
www.bioio.techCorporate Office
- 4340 Duncan Avenue
- Saint Louis, MO 63110
- United States
Corporate Office
- 4340 Duncan Avenue
- Saint Louis, MO 63110
- United States
Bioio Timeline
Bioio Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Later Stage VC | 01-May-2026 | Completed | Clinical Trials - General | |||
| 3. Seed Round | 01-Feb-2024 | Completed | Clinical Trials - General | |||
| 2. Grant | 01-Jan-2020 | $1.72M | Completed | Clinical Trials - General | ||
| 1. Grant | 17-Sep-2019 | $224K | Completed | Startup |
Bioio Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Seed-1 | ||||||||
| Seed |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
Bioio Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Bioio Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Bioio Investors (6)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| LifeSpan Vision Ventures | Venture Capital | Minority | ||
| BioGenerator Ventures | Venture Capital | Minority | ||
| Missouri Technology Corporation | Venture Capital | Minority | ||
| quadraScope Ventures | Venture Capital | Minority | ||
| National Institute of General Medical Sciences | Government |
Bioio FAQs
-
When was Bioio founded?
Bioio was founded in 2019.
-
Where is Bioio headquartered?
Bioio is headquartered in Saint Louis, MO.
-
What is the size of Bioio?
Bioio has 3 total employees.
-
What industry is Bioio in?
Bioio’s primary industry is Drug Discovery.
-
Is Bioio a private or public company?
Bioio is a Private company.
-
What is Bioio’s current revenue?
The current revenue for Bioio is .
-
How much funding has Bioio raised over time?
Bioio has raised $3M.
-
Who are Bioio’s investors?
LifeSpan Vision Ventures, BioGenerator Ventures, Missouri Technology Corporation, quadraScope Ventures, and National Institute of General Medical Sciences are 5 of 6 investors who have invested in Bioio.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
